- Home
- XERS vs GNK Comparison
XERS vs GNK Comparison
Compare XERS & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- GNK
- Stock Information
- Founded
- XERS 2005
- GNK 2004
- Country
- XERS United States
- GNK United States
- Employees
- XERS N/A
- GNK N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- GNK Marine Transportation
- Sector
- XERS Health Care
- GNK Consumer Discretionary
- Exchange
- XERS Nasdaq
- GNK Nasdaq
- Market Cap
- XERS 526.3M
- GNK 596.0M
- IPO Year
- XERS 2018
- GNK 2005
- Fundamental
- Price
- XERS $3.70
- GNK $14.65
- Analyst Decision
- XERS Buy
- GNK Strong Buy
- Analyst Count
- XERS 3
- GNK 5
- Target Price
- XERS $4.87
- GNK $24.20
- AVG Volume (30 Days)
- XERS 1.6M
- GNK 407.7K
- Earning Date
- XERS 03-05-2025
- GNK 02-19-2025
- Dividend Yield
- XERS N/A
- GNK 10.60%
- EPS Growth
- XERS N/A
- GNK 527.82
- EPS
- XERS N/A
- GNK 1.58
- Revenue
- XERS $187,361,000.00
- GNK $439,330,000.00
- Revenue This Year
- XERS $24.64
- GNK $7.38
- Revenue Next Year
- XERS $19.04
- GNK N/A
- P/E Ratio
- XERS N/A
- GNK $9.35
- Revenue Growth
- XERS 22.72
- GNK 11.14
- 52 Week Low
- XERS $1.69
- GNK $13.51
- 52 Week High
- XERS $3.87
- GNK $23.43
- Technical
- Relative Strength Index (RSI)
- XERS 62.63
- GNK 52.85
- Support Level
- XERS $3.47
- GNK $13.98
- Resistance Level
- XERS $3.78
- GNK $14.86
- Average True Range (ATR)
- XERS 0.16
- GNK 0.39
- MACD
- XERS 0.03
- GNK 0.08
- Stochastic Oscillator
- XERS 84.13
- GNK 77.42
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.